Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition
ACS Applied Materials & Interfaces · 05.08.2026 · 18 (30) · 40461-40475
DOI: 10.1021/acsami.6c10454 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 20.07.2026. Verfasst von Lujie Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China. Hauptthemen laut MEDLINE: Nanoparticles, Atherosclerosis, Prodrugs, TOR Serine-Threonine Kinases. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Atherosclerosis remains a major threat to human health due to unresolved plaque inflammation and macrophage dysfunction. Although stimuli-responsive nanocarriers (e.g., pH- or ROS-sensitive systems) have been exploited for targeted drug delivery, they suffer from modest signal gradients, spatial heterogeneity, or unpredictable release in atherosclerotic lesions. Herein, we report an esterase-responsive, carrier-free self-assembling prodrug nano-platform (LPNP) that exploits the unique pathological microenvironment of atherosclerotic plaques for targeted mTOR inhibition in lesional macrophages. The dual mTORC1/2 inhibitor Torkinib (PP242) was covalently conjugated to linoleic acid (LA) via a labile ester bond, enabling spontaneous nanoparticle formation without exogenous carriers. This ester bond remains stable during systemic circulation but is efficiently cleaved by intracellular esterases—highly active in macrophage-derived foam cells—enabling lesion-specific drug release. In vitro, LPNPs were readily internalized by macrophages, where they suppressed S6K phosphorylation, activated autophagy, reduced ROS levels, and upregulated ABCA1/ABCG1-mediated cholesterol efflux, thereby reducing lipid droplet accumulation and promoting M1-to-M2 repolarization. In an ApoE–/– mouse model, LPNP administration significantly reduced plaque burden, increased collagen deposition, and enhanced plaque stability without altering systemic lipid profiles or causing overt toxicity. Collectively, this esterase-responsive prodrug strategy couples carrier-free self-assembly with macrophage-associated intracellular activation, providing a promising approach to enhance lesional macrophage mTOR inhibition for atherosclerosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China.
- Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China.
- Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang315010, China.
- Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina27705, United States.
ORCID-Profile: Jiaxi Shen
Förderung
- Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhu, L., Li, T., Yan, Y., Shang, J., Du, Y., Zhou, T., Yang, F., Cui, H., Huangfu, N., & Shen, J. (2026). Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition. ACS Applied Materials & Interfaces, 18(30), 40461-40475. https://doi.org/10.1021/acsami.6c10454
Vancouver
Zhu L, Li T, Yan Y, Shang J, Du Y, Zhou T, et al. Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition. ACS Applied Materials & Interfaces. 2026;18(30):40461-40475. doi:10.1021/acsami.6c10454
BibTeX
@article{Zhu2026,
author = {Zhu, Lujie and Li, Tongyu and Yan, Yuyun and Shang, Jinhui and Du, Yantao and Zhou, Tianhui and Yang, Fangkun and Cui, Hanbin and Huangfu, Ning and Shen, Jiaxi},
title = {Esterase-Responsive Self-Assembled Torkinib Prodrug Nanoparticles Alleviate Atherosclerosis via Macrophage mTOR Inhibition},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {30},
pages = {40461--40475},
doi = {10.1021/acsami.6c10454}
}
EUVIMED